DRISCOLL FREDERICK W

CIK 000112989012 companiesFLORHAM PARK, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001129890

Recent Transactions

50 trades

Award
Cellectar Biosciences, Inc.$CLRB
Stock option (right to buy)
2026-07-07+25,000→ 25,000 total
Award
Lite Strategy, Inc.$LITS
Stock Option (Right to Buy)
2025-11-14+55,000→ 55,000 total
Award
Lite Strategy, Inc.$LITS
Stock Option (Right to Buy)
2025-07-15+20,000→ 20,000 total
Award
Cellectar Biosciences, Inc.$CLRB
Stock option (right to buy)
2025-02-14+60,000→ 60,000 total
Award
Cue Biopharma, Inc.$CUE
Stock Option (right to buy)
2025-01-02+24,400→ 24,400 total
Award
Cellectar Biosciences, Inc.$CLRB
Stock option (right to buy)
2024-06-14+60,000→ 60,000 total
Award
Cue Biopharma, Inc.$CUE
Stock Option (right to buy)
2024-01-02+24,400→ 24,400 total
Award
Lite Strategy, Inc.$LITS
Stock Option (Right to Buy)
2023-09-29+10,000→ 10,000 total
Award
Cellectar Biosciences, Inc.$CLRB
Stock option (right to buy)
2023-06-28+25,000→ 47,650 total
Award
Cue Biopharma, Inc.$CUE
Stock Option (right to buy)
2023-01-03+10,000→ 10,000 total
Award
Lite Strategy, Inc.$LITS
Stock Option (Right to Buy)
2022-07-05+87.5→ 87,500 total
Award
Cellectar Biosciences, Inc.$CLRB
Stock option (right to buy)
2022-06-24+7,800→ 7,800 total
Award
Renovacor, Inc.
Option
2022-03-28+155,325→ 155,325 total
Award
Cue Biopharma, Inc.$CUE
Stock Option (right to buy)
2022-01-03+10,000→ 10,000 total
Disposition to Issuer
Flexion Therapeutics Inc
Common Stock
2021-11-19$8.50/sh−30,680→ 0 total
Disposition to Issuer
Flexion Therapeutics Inc
Stock option (right to buy)
2021-11-19−168,000→ 0 total
Purchase
Cellectar Biosciences, Inc.$CLRB
Common Stock
2021-09-03$1.04/sh+19,417→ 19,417 total
Award
Lite Strategy, Inc.$LITS
Stock Option (Right to Buy)
2021-07-01+50,000→ 50,000 total
Award
Cellectar Biosciences, Inc.$CLRB
Stock option (right to buy)
2021-06-30+78,000→ 78,000 total
Award
Flexion Therapeutics Inc
Stock option (right to buy)
2021-06-01+168,000→ 168,000 total
Award
Flexion Therapeutics Inc
Common Stock
2021-06-01+28,000→ 30,680 total
Sale
Lite Strategy, Inc.$LITS
Common Stock
2021-02-23$4.03/sh−25,000→ 37,500 total
Award
Cue Biopharma, Inc.$CUE
Stock Option (right to buy)
2021-01-04+10,000→ 10,000 total
Sale
ImmunityBio, Inc.$IBRX
Common Stock
2020-08-11$10.77/sh−5,300→ 109,235 total
Sale
ImmunityBio, Inc.$IBRX
Common Stock
2020-08-11$9.98/sh−10,000→ 114,535 total
Sale
ImmunityBio, Inc.$IBRX
Common Stock
2020-08-11$10.22/sh−50,000→ 124,535 total
Award
Lite Strategy, Inc.$LITS
Stock Option (Right to Buy)
2020-07-02+50,000→ 50,000 total
Award
Cellectar Biosciences, Inc.$CLRB
Stock option (right to buy)
2020-06-24+50,000→ 50,000 total
Award
ImmunityBio, Inc.$IBRX
Stock Option (right to buy)
2020-06-10+100,000→ 100,000 total
Award
Cue Biopharma, Inc.$CUE
Stock Option (right to buy)
2020-01-02+8,000→ 8,000 total
Purchase
Lite Strategy, Inc.$LITS
Common Stock
2019-12-19$1.60/sh+62,500→ 62,500 total
Award
Lite Strategy, Inc.$LITS
Stock Option (Right to Buy)
2019-07-01+40,000→ 40,000 total
Award
Cellectar Biosciences, Inc.$CLRB
Stock option (right to buy)
2019-06-13+6,500→ 6,500 total
Award
ImmunityBio, Inc.$IBRX
Common Stock
2019-06-06+92,592→ 174,535 total
Award
Cue Biopharma, Inc.$CUE
Stock Option (right to buy)
2019-01-02+8,000→ 8,000 total
Award
Cellectar Biosciences, Inc.$CLRB
Stock option (right to buy)
2018-10-12+13,000→ 13,000 total
Award
Lite Strategy, Inc.$LITS
Stock Option (Right to Buy)
2018-07-12+40,000→ 40,000 total
Award
Cue Biopharma, Inc.$CUE
Stock Option (right to buy)
2018-06-26+50,000→ 50,000 total
Award
ImmunityBio, Inc.$IBRX
Common Stock
2018-06-07+27,322→ 81,943 total
Award
Lite Strategy, Inc.$LITS
Options to purchase shares of common stock
2018-02-22+33,333→ 33,333 total
Award
ImmunityBio, Inc.$IBRX
Common Stock
2017-09-18+54,621→ 54,621 total
Award
Cellectar Biosciences, Inc.$CLRB
Stock option (right to buy)
2017-05-31+10,000→ 10,000 total
Exercise/Conversion
Flexion Therapeutics Inc
Common Stock
2017-03-23$7.89/sh+3,000→ 10,777 total
Sale
Flexion Therapeutics Inc
Common Stock
2017-03-23$23.00/sh−3,000→ 7,777 total
Exercise/Conversion
Flexion Therapeutics Inc
Stock option (right to buy)
2017-03-23−3,000→ 102,300 total
Sale
Flexion Therapeutics Inc
Common Stock
2017-02-28$20.42/sh−600→ 7,777 total
Exercise/Conversion
Flexion Therapeutics Inc
Stock option (right to buy)
2017-02-28−30,000→ 105,300 total
Exercise/Conversion
Flexion Therapeutics Inc
Common Stock
2017-02-28$7.89/sh+30,000→ 41,211 total
Sale
Flexion Therapeutics Inc
Common Stock
2017-02-28$19.96/sh−32,834→ 8,377 total
Award
Flexion Therapeutics Inc
Stock option (right to buy)
2016-12-20+50,000→ 50,000 total

Companies

Recent Filings

Address

C/O CELLECTAR BIOSCIENCES, INC. 100 CAMPUS DRIVE

FLORHAM PARK, NJ, 07932

View on SEC.gov